ID   UBR2_HUMAN              Reviewed;        1755 AA.
AC   Q8IWV8; O15057; Q4VXK2; Q5TFH6; Q6P2I2; Q6ZUD0;
DT   16-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   10-MAY-2017, entry version 141.
DE   RecName: Full=E3 ubiquitin-protein ligase UBR2;
DE            EC=2.3.2.27;
DE   AltName: Full=N-recognin-2;
DE   AltName: Full=RING-type E3 ubiquitin transferase UBR2;
DE   AltName: Full=Ubiquitin-protein ligase E3-alpha-2;
DE   AltName: Full=Ubiquitin-protein ligase E3-alpha-II;
GN   Name=UBR2; Synonyms=C6orf133, KIAA0349;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   FUNCTION.
RX   PubMed=15548684; DOI=10.1158/0008-5472.CAN-04-2102;
RA   Kwak K.S., Zhou X., Solomon V., Baracos V.E., Davis J., Bannon A.W.,
RA   Boyle W.J., Lacey D.L., Han H.Q.;
RT   "Regulation of protein catabolism by muscle-specific and cytokine-
RT   inducible ubiquitin ligase E3alpha-II during cancer cachexia.";
RL   Cancer Res. 64:8193-8198(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 481-1755 (ISOFORMS 1/4), AND
RP   VARIANT THR-1095.
RC   TISSUE=Brain;
RX   PubMed=9205841; DOI=10.1093/dnares/4.2.141;
RA   Nagase T., Ishikawa K., Nakajima D., Ohira M., Seki N., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VII.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 4:141-150(1997).
RN   [6]
RP   INTERACTION WITH RECQL4, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15317757; DOI=10.1093/hmg/ddh269;
RA   Yin J., Kwon Y.T., Varshavsky A., Wang W.;
RT   "RECQL4, mutated in the Rothmund-Thomson and RAPADILINO syndromes,
RT   interacts with ubiquitin ligases UBR1 and UBR2 of the N-end rule
RT   pathway.";
RL   Hum. Mol. Genet. 13:2421-2430(2004).
RN   [7]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=16311597; DOI=10.1038/ng1681;
RA   Zenker M., Mayerle J., Lerch M.M., Tagariello A., Zerres K.,
RA   Durie P.R., Beier M., Hulskamp G., Guzman C., Rehder H., Beemer F.A.,
RA   Hamel B.C.J., Vanlieferinghen P., Gershoni-Baruch R., Vieira M.W.,
RA   Dumic M., Auslender R., Gil-da-Silva-Lopes V.L., Steinlicht S.,
RA   Rauh M., Shalev S.A., Thiel C., Winterpacht A., Kwon Y.T.,
RA   Varshavsky A., Reis A.;
RT   "Deficiency of UBR1, a ubiquitin ligase of the N-end rule pathway,
RT   causes pancreatic dysfunction, malformations and mental retardation
RT   (Johanson-Blizzard syndrome).";
RL   Nat. Genet. 37:1345-1350(2005).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   FUNCTION.
RX   PubMed=20298436; DOI=10.1111/j.1365-2443.2010.01385.x;
RA   Kume K., Iizumi Y., Shimada M., Ito Y., Kishi T., Yamaguchi Y.,
RA   Handa H.;
RT   "Role of N-end rule ubiquitin ligases UBR1 and UBR2 in regulating the
RT   leucine-mTOR signaling pathway.";
RL   Genes Cells 15:339-349(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 98-167 ALONE AND IN COMPLEX
RP   WITH N-END RULE PEPTIDE, UBR-TYPE ZINC FINGER, AND FUNCTION.
RX   PubMed=20835242; DOI=10.1038/nsmb.1894;
RA   Matta-Camacho E., Kozlov G., Li F.F., Gehring K.;
RT   "Structural basis of substrate recognition and specificity in the N-
RT   end rule pathway.";
RL   Nat. Struct. Mol. Biol. 17:1182-1187(2010).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase which is a component of the
CC       N-end rule pathway. Recognizes and binds to proteins bearing
CC       specific N-terminal residues that are destabilizing according to
CC       the N-end rule, leading to their ubiquitination and subsequent
CC       degradation. Plays a critical role in chromatin inactivation and
CC       chromosome-wide transcriptional silencing during meiosis via
CC       ubiquitination of histone H2A. Binds leucine and is a negative
CC       regulator of the leucine-mTOR signaling pathway, thereby
CC       controlling cell growth. {ECO:0000269|PubMed:15548684,
CC       ECO:0000269|PubMed:20298436, ECO:0000269|PubMed:20835242}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with UBE2B; promotes the UBE2B-H2A interaction
CC       and the ubiquitination of histone H2A by UBE2B and UBR2 (By
CC       similarity). Interacts with RECQL4. {ECO:0000250,
CC       ECO:0000269|PubMed:15317757, ECO:0000269|PubMed:20835242}.
CC   -!- INTERACTION:
CC       P12504:vif (xeno); NbExp=3; IntAct=EBI-1237260, EBI-779991;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Note=Associated with
CC       chromatin during meiosis.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q8IWV8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IWV8-2; Sequence=VSP_015167, VSP_015168;
CC       Name=3;
CC         IsoId=Q8IWV8-3; Sequence=VSP_015166, VSP_015169, VSP_015170,
CC                                  VSP_015171;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q8IWV8-4; Sequence=VSP_017130;
CC         Note=Derived from mouse cDNA data. No experimental confirmation
CC         available.;
CC   -!- TISSUE SPECIFICITY: Broadly expressed, with highest levels in
CC       skeletal muscle, kidney and pancreas. Present in acinar cells of
CC       the pancreas (at protein level). {ECO:0000269|PubMed:15548684,
CC       ECO:0000269|PubMed:16311597}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in fetal pancreas.
CC       {ECO:0000269|PubMed:16311597}.
CC   -!- DOMAIN: The RING-H2 zinc finger is an atypical RING finger with a
CC       His ligand in place of the fourth Cys of the classical motif.
CC   -!- DOMAIN: The UBR-type zinc finger forms a pocket that mediates
CC       recognition of type 1 N-degrons. It exhibits preference for
CC       Arginine in first position, has poor affinity for histidine, and
CC       doesn't bind acetylated peptides.
CC   -!- SIMILARITY: Belongs to the UBR1 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY061884; AAL32101.1; -; mRNA.
DR   EMBL; AK125795; BAC86295.1; -; mRNA.
DR   EMBL; AL049843; CAI20399.1; -; Genomic_DNA.
DR   EMBL; AL136223; CAI20399.1; JOINED; Genomic_DNA.
DR   EMBL; AL391814; CAI20399.1; JOINED; Genomic_DNA.
DR   EMBL; AL049843; CAI95685.1; -; Genomic_DNA.
DR   EMBL; AL136223; CAI95685.1; JOINED; Genomic_DNA.
DR   EMBL; AL391814; CAI95685.1; JOINED; Genomic_DNA.
DR   EMBL; AL136223; CAI19919.1; -; Genomic_DNA.
DR   EMBL; AL391814; CAI19919.1; JOINED; Genomic_DNA.
DR   EMBL; AL136223; CAI19920.1; -; Genomic_DNA.
DR   EMBL; AL049843; CAI19920.1; JOINED; Genomic_DNA.
DR   EMBL; AL391814; CAI19920.1; JOINED; Genomic_DNA.
DR   EMBL; AL136223; CAI95666.1; -; Genomic_DNA.
DR   EMBL; AL049843; CAI95666.1; JOINED; Genomic_DNA.
DR   EMBL; AL391814; CAI95666.1; JOINED; Genomic_DNA.
DR   EMBL; AL391814; CAI14737.1; -; Genomic_DNA.
DR   EMBL; AL136223; CAI14737.1; JOINED; Genomic_DNA.
DR   EMBL; AL391814; CAI14738.1; -; Genomic_DNA.
DR   EMBL; AL136223; CAI14738.1; JOINED; Genomic_DNA.
DR   EMBL; AL049843; CAI14738.1; JOINED; Genomic_DNA.
DR   EMBL; AL391814; CAI95298.1; -; Genomic_DNA.
DR   EMBL; AL049843; CAI95298.1; JOINED; Genomic_DNA.
DR   EMBL; AL136223; CAI95298.1; JOINED; Genomic_DNA.
DR   EMBL; BC024217; AAH24217.1; -; mRNA.
DR   EMBL; BC064512; AAH64512.1; -; mRNA.
DR   EMBL; AB002347; BAA20806.1; -; mRNA.
DR   CCDS; CCDS4870.1; -. [Q8IWV8-1]
DR   CCDS; CCDS55001.1; -. [Q8IWV8-2]
DR   RefSeq; NP_001171730.1; NM_001184801.1. [Q8IWV8-2]
DR   RefSeq; NP_056070.1; NM_015255.2. [Q8IWV8-1]
DR   RefSeq; XP_005249022.1; XM_005248965.4. [Q8IWV8-4]
DR   UniGene; Hs.529925; -.
DR   PDB; 3NY2; X-ray; 2.61 A; A/B/C/D/E/F/G/H=98-167.
DR   PDB; 3NY3; X-ray; 1.60 A; A=98-167.
DR   PDB; 5TDA; X-ray; 0.79 A; A=98-168.
DR   PDB; 5TDB; X-ray; 1.10 A; A=98-168.
DR   PDB; 5TDD; X-ray; 1.55 A; A=98-168.
DR   PDB; 5UM3; X-ray; 1.20 A; A=98-167.
DR   PDBsum; 3NY2; -.
DR   PDBsum; 3NY3; -.
DR   PDBsum; 5TDA; -.
DR   PDBsum; 5TDB; -.
DR   PDBsum; 5TDD; -.
DR   PDBsum; 5UM3; -.
DR   ProteinModelPortal; Q8IWV8; -.
DR   SMR; Q8IWV8; -.
DR   BioGrid; 116896; 64.
DR   DIP; DIP-38165N; -.
DR   IntAct; Q8IWV8; 16.
DR   STRING; 9606.ENSP00000361990; -.
DR   iPTMnet; Q8IWV8; -.
DR   PhosphoSitePlus; Q8IWV8; -.
DR   BioMuta; UBR2; -.
DR   DMDM; 73622073; -.
DR   EPD; Q8IWV8; -.
DR   MaxQB; Q8IWV8; -.
DR   PaxDb; Q8IWV8; -.
DR   PeptideAtlas; Q8IWV8; -.
DR   PRIDE; Q8IWV8; -.
DR   Ensembl; ENST00000372899; ENSP00000361990; ENSG00000024048. [Q8IWV8-1]
DR   Ensembl; ENST00000372901; ENSP00000361992; ENSG00000024048. [Q8IWV8-4]
DR   Ensembl; ENST00000372903; ENSP00000361994; ENSG00000024048. [Q8IWV8-2]
DR   GeneID; 23304; -.
DR   KEGG; hsa:23304; -.
DR   UCSC; uc003osf.4; human. [Q8IWV8-1]
DR   CTD; 23304; -.
DR   DisGeNET; 23304; -.
DR   GeneCards; UBR2; -.
DR   HGNC; HGNC:21289; UBR2.
DR   HPA; HPA027869; -.
DR   HPA; HPA027880; -.
DR   MIM; 609134; gene.
DR   neXtProt; NX_Q8IWV8; -.
DR   OpenTargets; ENSG00000024048; -.
DR   PharmGKB; PA128394621; -.
DR   eggNOG; KOG1140; Eukaryota.
DR   eggNOG; ENOG410XPQU; LUCA.
DR   GeneTree; ENSGT00530000063055; -.
DR   HOGENOM; HOG000231769; -.
DR   HOVERGEN; HBG080426; -.
DR   InParanoid; Q8IWV8; -.
DR   KO; K10626; -.
DR   OMA; ANCLVYD; -.
DR   OrthoDB; EOG091G009K; -.
DR   PhylomeDB; Q8IWV8; -.
DR   TreeFam; TF323875; -.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SIGNOR; Q8IWV8; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; UBR2; human.
DR   EvolutionaryTrace; Q8IWV8; -.
DR   GeneWiki; UBR2; -.
DR   GenomeRNAi; 23304; -.
DR   PRO; PR:Q8IWV8; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000024048; -.
DR   CleanEx; HS_UBR2; -.
DR   Genevisible; Q8IWV8; HS.
DR   GO; GO:0000785; C:chromatin; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0000151; C:ubiquitin ligase complex; IBA:GO_Central.
DR   GO; GO:0070728; F:leucine binding; IDA:UniProtKB.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IBA:GO_Central.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; EXP:Reactome.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0071233; P:cellular response to leucine; IDA:UniProtKB.
DR   GO; GO:0006342; P:chromatin silencing; ISS:UniProtKB.
DR   GO; GO:0033522; P:histone H2A ubiquitination; ISS:UniProtKB.
DR   GO; GO:0007141; P:male meiosis I; IEA:Ensembl.
DR   GO; GO:0032007; P:negative regulation of TOR signaling; IMP:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; TAS:Reactome.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   GO; GO:0071596; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway; IBA:GO_Central.
DR   Gene3D; 3.30.1390.10; -; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR003769; ClpS_core.
DR   InterPro; IPR014719; Ribosomal_L7/12_C/ClpS-like.
DR   InterPro; IPR011991; WHTH_DNA-bd_dom.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR003126; Znf_UBR.
DR   Pfam; PF02617; ClpS; 1.
DR   Pfam; PF02207; zf-UBR; 1.
DR   SMART; SM00396; ZnF_UBR1; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF54736; SSF54736; 1.
DR   PROSITE; PS51157; ZF_UBR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Coiled coil;
KW   Complete proteome; Metal-binding; Nucleus; Polymorphism;
KW   Reference proteome; Transferase; Ubl conjugation pathway; Zinc;
KW   Zinc-finger.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   CHAIN         2   1755       E3 ubiquitin-protein ligase UBR2.
FT                                /FTId=PRO_0000056140.
FT   ZN_FING      97    168       UBR-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00508}.
FT   ZN_FING    1108   1214       RING-type; atypical.
FT   COILED     1019   1054       {ECO:0000255}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   VAR_SEQ       1    496       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_015166.
FT   VAR_SEQ     397    439       QQLQRDFMEDDHERAVSVTALSVQFFTAPTLARMLITEENL
FT                                MS -> ERLQSDYVTDDHDREFSVADLSVQIFTVPSLFSIS
FT                                AGRSGSPL (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_015167.
FT   VAR_SEQ     397    426       QQLQRDFMEDDHERAVSVTALSVQFFTAPT -> ERLQSDY
FT                                VTDDHDREFSVADLSVQIFTVPS (in isoform 4).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_017130.
FT   VAR_SEQ     440   1755       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_015168.
FT   VAR_SEQ     497    514       RQKFLEGFDAFLELLKCM -> MYAGNIPIYKTESRSRNE
FT                                (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_015169.
FT   VAR_SEQ    1022   1071       SSRDKDKAERKRKAEIARLRREKIMAQMSEMQRHFIDENKE
FT                                LFQQTLELD -> HNFRVQGTKTKLRGREKQRLPDCAEKRS
FT                                WLRCLKCSGILLMKTKNSFSRH (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_015170.
FT   VAR_SEQ    1072   1755       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_015171.
FT   VARIANT     172    172       E -> D (in dbSNP:rs6905054).
FT                                /FTId=VAR_052117.
FT   VARIANT    1095   1095       A -> P (in dbSNP:rs6917033).
FT                                /FTId=VAR_059816.
FT   VARIANT    1095   1095       A -> S (in dbSNP:rs6917033).
FT                                /FTId=VAR_059817.
FT   VARIANT    1095   1095       A -> T (in dbSNP:rs6917033).
FT                                {ECO:0000269|PubMed:9205841}.
FT                                /FTId=VAR_023283.
FT   CONFLICT    864    864       K -> R (in Ref. 2; BAC86295).
FT                                {ECO:0000305}.
FT   STRAND      108    112       {ECO:0000244|PDB:3NY3}.
FT   TURN        113    115       {ECO:0000244|PDB:3NY3}.
FT   STRAND      116    118       {ECO:0000244|PDB:3NY3}.
FT   HELIX       125    129       {ECO:0000244|PDB:3NY3}.
FT   HELIX       132    135       {ECO:0000244|PDB:3NY3}.
FT   STRAND      138    142       {ECO:0000244|PDB:3NY3}.
FT   TURN        154    156       {ECO:0000244|PDB:3NY3}.
FT   STRAND      157    159       {ECO:0000244|PDB:3NY3}.
FT   TURN        164    166       {ECO:0000244|PDB:3NY3}.
SQ   SEQUENCE   1755 AA;  200538 MW;  04B14FCB13E21808 CRC64;
     MASELEPEVQ AIDRSLLECS AEEIAGKWLQ ATDLTREVYQ HLAHYVPKIY CRGPNPFPQK
     EDMLAQHVLL GPMEWYLCGE DPAFGFPKLE QANKPSHLCG RVFKVGEPTY SCRDCAVDPT
     CVLCMECFLG SIHRDHRYRM TTSGGGGFCD CGDTEAWKEG PYCQKHELNT SEIEEEEDPL
     VHLSEDVIAR TYNIFAITFR YAVEILTWEK ESELPADLEM VEKSDTYYCM LFNDEVHTYE
     QVIYTLQKAV NCTQKEAIGF ATTVDRDGRR SVRYGDFQYC EQAKSVIVRN TSRQTKPLKV
     QVMHSSIVAH QNFGLKLLSW LGSIIGYSDG LRRILCQVGL QEGPDGENSS LVDRLMLSDS
     KLWKGARSVY HQLFMSSLLM DLKYKKLFAV RFAKNYQQLQ RDFMEDDHER AVSVTALSVQ
     FFTAPTLARM LITEENLMSI IIKTFMDHLR HRDAQGRFQF ERYTALQAFK FRRVQSLILD
     LKYVLISKPT EWSDELRQKF LEGFDAFLEL LKCMQGMDPI TRQVGQHIEM EPEWEAAFTL
     QMKLTHVISM MQDWCASDEK VLIEAYKKCL AVLMQCHGGY TDGEQPITLS ICGHSVETIR
     YCVSQEKVSI HLPVSRLLAG LHVLLSKSEV AYKFPELLPL SELSPPMLIE HPLRCLVLCA
     QVHAGMWRRN GFSLVNQIYY YHNVKCRREM FDKDVVMLQT GVSMMDPNHF LMIMLSRFEL
     YQIFSTPDYG KRFSSEITHK DVVQQNNTLI EEMLYLIIML VGERFSPGVG QVNATDEIKR
     EIIHQLSIKP MAHSELVKSL PEDENKETGM ESVIEAVAHF KKPGLTGRGM YELKPECAKE
     FNLYFYHFSR AEQSKAEEAQ RKLKRQNRED TALPPPVLPP FCPLFASLVN ILQSDVMLCI
     MGTILQWAVE HNGYAWSESM LQRVLHLIGM ALQEEKQHLE NVTEEHVVTF TFTQKISKPG
     EAPKNSPSIL AMLETLQNAP YLEVHKDMIR WILKTFNAVK KMRESSPTSP VAETEGTIME
     ESSRDKDKAE RKRKAEIARL RREKIMAQMS EMQRHFIDEN KELFQQTLEL DASTSAVLDH
     SPVASDMTLT ALGPAQTQVP EQRQFVTCIL CQEEQEVKVE SRAMVLAAFV QRSTVLSKNR
     SKFIQDPEKY DPLFMHPDLS CGTHTSSCGH IMHAHCWQRY FDSVQAKEQR RQQRLRLHTS
     YDVENGEFLC PLCECLSNTV IPLLLPPRNI FNNRLNFSDQ PNLTQWIRTI SQQIKALQFL
     RKEESTPNNA STKNSENVDE LQLPEGFRPD FRPKIPYSES IKEMLTTFGT ATYKVGLKVH
     PNEEDPRVPI MCWGSCAYTI QSIERILSDE DKPLFGPLPC RLDDCLRSLT RFAAAHWTVA
     SVSVVQGHFC KLFASLVPND SHEELPCILD IDMFHLLVGL VLAFPALQCQ DFSGISLGTG
     DLHIFHLVTM AHIIQILLTS CTEENGMDQE NPPCEEESAV LALYKTLHQY TGSALKEIPS
     GWHLWRSVRA GIMPFLKCSA LFFHYLNGVP SPPDIQVPGT SHFEHLCSYL SLPNNLICLF
     QENSEIMNSL IESWCRNSEV KRYLEGERDA IRYPRESNKL INLPEDYSSL INQASNFSCP
     KSGGDKSRAP TLCLVCGSLL CSQSYCCQTE LEGEDVGACT AHTYSCGSGV GIFLRVRECQ
     VLFLAGKTKG CFYSPPYLDD YGETDQGLRR GNPLHLCKER FKKIQKLWHQ HSVTEEIGHA
     QEANQTLVGI DWQHL
//
